Cardiac Drugs
2nd Edition
Will be published approx. on 31. August 2015
Book
Paperback/Softback
550 pages
978-93-5152-851-7 (ISBN)
Description
Cardiac Drugs is the latest edition of this comprehensive resource, completely revised to provide up-to-date information on the rapidly evolving field of cardiovascular drugs.
The book is divided into thirteen chapters, focusing on cardiovascular comorbid conditions, with extensive coverage of cardiovascular disease management in patients with co-existing diabetes, dysmetabolic syndrome and pregnancy. The first two chapters cover vasodilators and neurohormone modulators, and positive inotropic drugs, and subsequent chapters cover drugs for specific conditions including dyslipidemia, dysrhythmia, stable angina, and pulmonary hypertension.
The final chapter 'Future Direction - Pharmacogenomics' provides insight into the exploration of the human genome for opportunities to improve therapeutic precision in cardiovascular medicine. This new edition of Cardiac Drugs also incorporates the latest JNC 8 (Joint National Committee) guidelines on hypertension, highlighting their key differences to previous guidelines.
Enhanced by 80 full colour illustrations and tables, and written by US based experts in cardiovascular pharmacology, Cardiac Drugs is an invaluable resource for cardiologists and pharmacologists.
Key Points
Latest edition of comprehensive guide to cardiovascular pharmacology
Incorporates JNC 8 guidelines on hypertension
80 full colour illustrations and tables
Written by US based experts in the field of cardiovascular pharmacology
Previous edition (9789350258798) published 2012
The book is divided into thirteen chapters, focusing on cardiovascular comorbid conditions, with extensive coverage of cardiovascular disease management in patients with co-existing diabetes, dysmetabolic syndrome and pregnancy. The first two chapters cover vasodilators and neurohormone modulators, and positive inotropic drugs, and subsequent chapters cover drugs for specific conditions including dyslipidemia, dysrhythmia, stable angina, and pulmonary hypertension.
The final chapter 'Future Direction - Pharmacogenomics' provides insight into the exploration of the human genome for opportunities to improve therapeutic precision in cardiovascular medicine. This new edition of Cardiac Drugs also incorporates the latest JNC 8 (Joint National Committee) guidelines on hypertension, highlighting their key differences to previous guidelines.
Enhanced by 80 full colour illustrations and tables, and written by US based experts in cardiovascular pharmacology, Cardiac Drugs is an invaluable resource for cardiologists and pharmacologists.
Key Points
Latest edition of comprehensive guide to cardiovascular pharmacology
Incorporates JNC 8 guidelines on hypertension
80 full colour illustrations and tables
Written by US based experts in the field of cardiovascular pharmacology
Previous edition (9789350258798) published 2012
More details
Edition
2nd Revised edition
Language
English
Place of publication
New Delhi
India
Target group
Professional and scholarly
Edition type
Revised edition
Illustrations
62 Tabellen, 18 Abbildungen
62 Tables, unspecified; 18 Illustrations
Dimensions
Height: 235 mm
Width: 108 mm
Weight
850 gr
ISBN-13
978-93-5152-851-7 (9789351528517)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Kanu Chatterjee MD FRCP (Edin) FRCP (Lond) FCCP FACC MACP
Clinical Professor of Medicine, The Carver College of Medicine, University of Iowa, Emeritus Professor of Medicine, University of California, San Francisco, 200 Hawkins Drive, Iowa City, USA
Eric J Topol
Professor of Translational Genomics, Division of Cardiovascular Diseases, Scripps Research Institute, MD, Director, Scripps Translational Science Institute, Chief Academic Officer, Scripps Health, La Jolla, California, USA
Clinical Professor of Medicine, The Carver College of Medicine, University of Iowa, Emeritus Professor of Medicine, University of California, San Francisco, 200 Hawkins Drive, Iowa City, USA
Eric J Topol
Professor of Translational Genomics, Division of Cardiovascular Diseases, Scripps Research Institute, MD, Director, Scripps Translational Science Institute, Chief Academic Officer, Scripps Health, La Jolla, California, USA
Content
Vasodilators and Neurohormone Modulators
Positive Inotropic Drugs
Drugs for Hypertension
Diuretics
Drugs for Dyslipidemia
Drugs for Diabetes and Cardiodysmetabolic Syndrome
Drugs for Acute Coronary Syndromes
Drugs for Dysrhythmia
Drugs for Heart Failure
Drugs for Stable Angina
Drugs for Pulmonary Hypertension
Cardiac Drugs in Pregnancy and Lactation
Future Direction- Pharmacogenomics
Positive Inotropic Drugs
Drugs for Hypertension
Diuretics
Drugs for Dyslipidemia
Drugs for Diabetes and Cardiodysmetabolic Syndrome
Drugs for Acute Coronary Syndromes
Drugs for Dysrhythmia
Drugs for Heart Failure
Drugs for Stable Angina
Drugs for Pulmonary Hypertension
Cardiac Drugs in Pregnancy and Lactation
Future Direction- Pharmacogenomics